Overview

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This is a multicenter study designed to compare the effect of exenatide plus a lifestyle modification plan versus placebo plus a lifestyle modification plan on weight loss in non-diabetic, obese subjects.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Eli Lilly and Company
Treatments:
Exenatide